What Is MGF?
MGF (Mechano Growth Factor, also IGF-1Ec) is an IGF-1 splice variant generated locally in muscle tissue in response to mechanical overload or injury. It serves as the body's critical early repair signal, acting independently of systemic IGF-1 by exerting powerful, localized, and transient effects. By activating quiescent satellite cells, MGF initiates the essential process of muscle tissue regeneration following micro-trauma.
Unlike its stabilized cousin PEG-MGF, native MGF lacks PEGylation, which results in a very short biological half-life. This ensures the signal remains strictly local and acute, mimicking the natural, tightly controlled mechanical response required to repair damaged myofibrils without triggering systemic hormonal alterations.
Mechanism of Action
Mechanical stress on skeletal muscle triggers the alternative splicing of the IGF-1 gene, resulting in the production of IGF-1Ec (MGF). The specific E-peptide domain (Ec) is primarily responsible for activating quiescent satellite cells, distinguishing its biological role from the mature IGF-1 domain which primarily drives growth. Once activated, these satellite cells proliferate and donate their nuclei to existing fibers, facilitating myonuclear accretion.
In addition to satellite cell activation, MGF triggers the PI3K/Akt and MAPK/ERK signaling pathways, which are critical for muscle protein synthesis and cell survival. Because MGF is not stabilized by PEGylation, its duration of action is transient, lasting only minutes to roughly one hour, ensuring a precise, localized repair stimulus at the site of mechanical load or injury.
Satellite Cell Activation and Muscle Regeneration
Satellite cells are Pax7+ myogenic stem cells that remain dormant on the periphery of muscle fibers until injury or intense mechanical loading occurs. MGF acts as a potent stimulator that compels these quiescent cells to re-enter the cell cycle, proliferate, and subsequently fuse with damaged muscle fibers to restore structural integrity.
The myonuclear domain theory suggests that a muscle fiber can only support a specific volume of cytoplasm; thus, the addition of new nuclei through MGF-induced satellite cell donation is fundamental for long-term hypertrophy and structural adaptation. Animal models consistently demonstrate that localized MGF administration significantly accelerates the recovery timeline and improves the quality of regenerated muscle tissue following traumatic injury.
Comparison with PEG-MGF
MGF represents the native, acute repair signal produced during exercise, characterized by its rapid degradation and localized, transient nature. This makes it ideal for protocols focusing on immediate post-training or post-injury intervention where a short-duration burst of activity is desired.
PEG-MGF, by contrast, is conjugated with polyethylene glycol to significantly extend its half-life, allowing for systemic availability and longer-acting growth support. While MGF is often used for the immediate post-workout window to capture the "mechanical trigger" effect, PEG-MGF is frequently utilized to provide a sustained environment for tissue healing. These agents are often employed in sequential or distinct protocols based on the specific repair requirements.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Mechano Growth Factor E peptide (MGF-E) activates human muscle progenitor cells
Kandalla PK, et al., 2011, Mechanisms of Ageing and Development - Overexpression of Mechano-Growth Factor modulates inflammatory cytokines
Doroudian G, et al., 2018, Frontiers in Physiology - Mechano-Growth Factor: A Putative Product of IGF-I Gene Expression
Matheny RW Jr, et al., 2010, Endocrinology - Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?
Philippou A, et al., 2012, Frontiers in Endocrinology - The emerging landscape of performance-enhancing peptides
Dominikowski A, et al., 2026, Frontiers in Endocrinology - Research on mechano-growth factor and muscle hypertrophy
Goldspink G., 2005, Journal of Physiology